Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director comp.
Appointed director
Inv. presentation
Quarterly results
|
|
Amneal Pharmaceuticals, Inc. (AMRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/07/2018 |
8-K
| Director compensation was amended/approved, Appointed a new director|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 4, 2018 Amneal Pharmaceuticals, Inc. Delaware 001-38485 32-0546926 c/o Amneal Pharmaceuticals LLC 400 Crossing Blvd., 3rd Floor Bridgewater, New Jersey 08807 Registrant's telephone number, including area code: 409-6700 Atlas Holdings, Inc. Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant ...",
"Purchase and Sale Agreement, by and among Amneal Phrmaceuticals LLC, Gemini Laboratories, LLC, the parties signatory thereto and the Sellers' Representative",
"Amended and Restated Certificate of Incorporation of Amneal Pharmaceuticals, Inc., adopted as of May 4, 2018",
"Amended and Restated Bylaws of Amneal Pharmaceuticals, Inc., adopted as of May 4, 2018",
"Second Supplemental Indenture",
"Term Loan Credit Agreement, by and among Amneal Pharmaceuticals LLC, as the borrower, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, and the lenders and other parties party thereto",
"Revolving Credit Agreement, by and among Amneal Pharmaceuticals LLC, as the borrower, the other loan parties from time to time party thereto, JPMorgan Chase Bank, N.A., as administrative agent and collateral agent and the lenders and other parties party thereto",
"Term Loan Guarantee and Collateral Agreement, by and among the loan parties from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent",
"Revolving Loan Guarantee and Collateral Agreement, by and among the loan parties from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent",
"Third Amended and Restated Limited Liability Company Agreement, adopted as of May 4, 2018",
"Tax Receivable Agreement, by and among Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and the Members of Amneal Pharmaceuticals LLC from time to time party thereto" |
|
|
|